Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cost-Effective Protein Production in CHO Cells Following Polyethylenimine-Mediated Gene Delivery Showcased by the Production and Crystallization of Antibody Fabs

K. Meskova, K. Martonova, P. Hrasnova, K. Sinska, M. Skrabanova, L. Fialova, S. Njemoga, O. Cehlar, O. Parmar, P. Kolenko, V. Pevala, R. Skrabana

. 2023 ; 12 (3) : . [pub] 20230804

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23015522

Grantová podpora
APVV-21-0479, APVV-20-0513 Slovak Research and Development Agency
2/0152/21, 2/0141/23, 2/0125/23 VEGA

Laboratory production of recombinant mammalian proteins, particularly antibodies, requires an expression pipeline assuring sufficient yield and correct folding with appropriate posttranslational modifications. Transient gene expression (TGE) in the suspension-adapted Chinese Hamster Ovary (CHO) cell lines has become the method of choice for this task. The antibodies can be secreted into the media, which facilitates subsequent purification, and can be glycosylated. However, in general, protein production in CHO cells is expensive and may provide variable outcomes, namely in laboratories without previous experience. While achievable yields may be influenced by the nucleotide sequence, there are other aspects of the process which offer space for optimization, like gene delivery method, cultivation process or expression plasmid design. Polyethylenimine (PEI)-mediated gene delivery is frequently employed as a low-cost alternative to liposome-based methods. In this work, we are proposing a TGE platform for universal medium-scale production of antibodies and other proteins in CHO cells, with a novel expression vector allowing fast and flexible cloning of new genes and secretion of translated proteins. The production cost has been further reduced using recyclable labware. Nine days after transfection, we routinely obtain milligrams of antibody Fabs or human lactoferrin in a 25 mL culture volume. Potential of the platform is established based on the production and crystallization of antibody Fabs and their complexes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015522
003      
CZ-PrNML
005      
20250923164533.0
007      
ta
008      
231010s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/antib12030051 $2 doi
035    __
$a (PubMed)37606435
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Meskova, Klaudia $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $u Faculty of Natural Sciences, Comenius University, 842 15 Bratislava, Slovakia
245    10
$a Cost-Effective Protein Production in CHO Cells Following Polyethylenimine-Mediated Gene Delivery Showcased by the Production and Crystallization of Antibody Fabs / $c K. Meskova, K. Martonova, P. Hrasnova, K. Sinska, M. Skrabanova, L. Fialova, S. Njemoga, O. Cehlar, O. Parmar, P. Kolenko, V. Pevala, R. Skrabana
520    9_
$a Laboratory production of recombinant mammalian proteins, particularly antibodies, requires an expression pipeline assuring sufficient yield and correct folding with appropriate posttranslational modifications. Transient gene expression (TGE) in the suspension-adapted Chinese Hamster Ovary (CHO) cell lines has become the method of choice for this task. The antibodies can be secreted into the media, which facilitates subsequent purification, and can be glycosylated. However, in general, protein production in CHO cells is expensive and may provide variable outcomes, namely in laboratories without previous experience. While achievable yields may be influenced by the nucleotide sequence, there are other aspects of the process which offer space for optimization, like gene delivery method, cultivation process or expression plasmid design. Polyethylenimine (PEI)-mediated gene delivery is frequently employed as a low-cost alternative to liposome-based methods. In this work, we are proposing a TGE platform for universal medium-scale production of antibodies and other proteins in CHO cells, with a novel expression vector allowing fast and flexible cloning of new genes and secretion of translated proteins. The production cost has been further reduced using recyclable labware. Nine days after transfection, we routinely obtain milligrams of antibody Fabs or human lactoferrin in a 25 mL culture volume. Potential of the platform is established based on the production and crystallization of antibody Fabs and their complexes.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Martonova, Katarina $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $u Faculty of Natural Sciences, Comenius University, 842 15 Bratislava, Slovakia
700    1_
$a Hrasnova, Patricia $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia
700    1_
$a Sinska, Kristina $u AXON Neuroscience R&D Services SE, 811 02 Bratislava, Slovakia
700    1_
$a Skrabanova, M. $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $7 xx0335110
700    1_
$a Fialova, Lubica $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $u AXON Neuroscience R&D Services SE, 811 02 Bratislava, Slovakia
700    1_
$a Njemoga, Stefana $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $u Faculty of Natural Sciences, Comenius University, 842 15 Bratislava, Slovakia
700    1_
$a Cehlar, Ondrej $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $1 https://orcid.org/0000000219966812
700    1_
$a Parmar, Olga $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia
700    1_
$a Kolenko, Petr $u Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, 115 19 Prague, Czech Republic
700    1_
$a Pevala, Vladimir $u Institute of Molecular Biology, Slovak Academy of Sciences, 845 51 Bratislava, Slovakia $1 https://orcid.org/0000000151108837
700    1_
$a Skrabana, Rostislav $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $1 https://orcid.org/0000000182005275
773    0_
$w MED00213964 $t Antibodies $x 2073-4468 $g Roč. 12, č. 3 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37606435 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20250923164529 $b ABA008
999    __
$a ok $b bmc $g 1997169 $s 1201884
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 12 $c 3 $e 20230804 $i 2073-4468 $m Antibodies $n Antibodies $x MED00213964
GRA    __
$a APVV-21-0479, APVV-20-0513 $p Slovak Research and Development Agency
GRA    __
$a 2/0152/21, 2/0141/23, 2/0125/23 $p VEGA
LZP    __
$a Pubmed-20231010

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...